DK0490955T3 - Behandling af insulinresistent diabetes - Google Patents

Behandling af insulinresistent diabetes

Info

Publication number: DK0490955T3
Authority: DK; Denmark
Prior art keywords: insulin; treatment; resistant diabetes; diabetes; syndrome
Prior art date: 1989-09-08

Application number

DK90913512.1T

Other languages

Danish (da)

English (en)

Inventor

Angus Carstairs Maccuish

Original Assignee

Fujisawa Pharmaceutical Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-09-08

Filing date

1990-09-10

Publication date

1996-06-24

1990-09-10 Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co

1996-06-24 Application granted granted Critical

1996-06-24 Publication of DK0490955T3 publication Critical patent/DK0490955T3/da

Links

206010022491 Insulin resistant diabetes Diseases 0.000 title abstract 2
201000005948 Donohue syndrome Diseases 0.000 abstract 2
108090000723 Insulin-Like Growth Factor I Proteins 0.000 abstract 2
102000013275 Somatomedins Human genes 0.000 abstract 2
206010053547 Congenital generalised lipodystrophy Diseases 0.000 abstract 1
201000006705 Congenital generalized lipodystrophy Diseases 0.000 abstract 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 1
208000035369 Leprechaunism Diseases 0.000 abstract 1
206010024604 Lipoatrophy Diseases 0.000 abstract 1
201000011032 Werner Syndrome Diseases 0.000 abstract 1
239000008103 glucose Substances 0.000 abstract 1
208000022215 lipoatrophic diabetes Diseases 0.000 abstract 1
201000009099 lipoatrophic diabetes mellitus Diseases 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Diabetes (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Endocrinology (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Obesity (AREA)
Molecular Biology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Hematology (AREA)
Emergency Medicine (AREA)
Organic Chemistry (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Epidemiology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

DK90913512.1T 1989-09-08 1990-09-10 Behandling af insulinresistent diabetes DK0490955T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB898920381A GB8920381D0 (en)	1989-09-08	1989-09-08	Treatment of insulin-resistant diabetes

Publications (1)

Publication Number	Publication Date
DK0490955T3 true DK0490955T3 (da)	1996-06-24

Family

ID=10662782

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK90913512.1T DK0490955T3 (da)	1989-09-08	1990-09-10	Behandling af insulinresistent diabetes

Country Status (11)

Country	Link
US (1)	US5674845A (de)
EP (1)	EP0490955B1 (de)
JP (1)	JP2513360B2 (de)
AT (1)	ATE138578T1 (de)
AU (1)	AU642665B2 (de)
CA (1)	CA2066227A1 (de)
DE (1)	DE69027217T2 (de)
DK (1)	DK0490955T3 (de)
ES (1)	ES2087162T3 (de)
GB (1)	GB8920381D0 (de)
WO (1)	WO1991003253A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5681814A (en) *	1990-06-07	1997-10-28	Genentech, Inc.	Formulated IGF-I Composition
SE9201573D0 (sv) *	1992-05-19	1992-05-19	Kabi Pharmacia Ab	Use of igf-1
JPH06510065A (ja) *	1992-06-08	1994-11-10	カイロン　コーポレーション	成長因子ｉｇｆ−ｉおよび／またはｉｇｆ−ｉｉの用法
WO1994016722A1 (en) *	1993-01-25	1994-08-04	The Beth Israel Hospital Association	Method for modifying, diagnosing, and screening for igf-i sensitive cell barrier properties
SE9402370D0 (sv)	1994-07-04	1994-07-04	Pharmacia Ab	Use of IGF-I
US5741776A (en) *	1995-05-22	1998-04-21	Genentech, Inc.	Method of administration of IGF-I
US5565428A (en) *	1995-05-22	1996-10-15	Genentech, Inc.	Method of administration of IGF-I
US5783556A (en) *	1996-08-13	1998-07-21	Genentech, Inc.	Formulated insulin-containing composition
CA2276149A1 (en) *	1996-12-24	1998-07-02	Fred I. Chasalow	Methods for treating insulin resistance and identifying patients at risk for the disease
US6121416A (en)	1997-04-04	2000-09-19	Genentech, Inc.	Insulin-like growth factor agonist molecules
US6420518B1 (en)	1997-04-04	2002-07-16	Genetech, Inc.	Insulin-like growth factor agonist molecules
US6627746B1 (en)	1998-04-17	2003-09-30	Exelixis, Inc.	Nucleic acids and proteins of C. elegans insulin-like genes and uses thereof
KR100606857B1 (ko) *	1998-07-08	2006-08-01	키린-암젠 인코포레이티드	고분자 의약품 함유 분말상 경점막 투여 제제
US6902898B2 (en) *	1998-11-16	2005-06-07	National Institute Of Advanced Industrial Science And Technology	Human derived bradeion proteins, DNA coding for the proteins, and uses thereof
JP3141107B2 (ja) *	1998-11-16	2001-03-05	工業技術院長	ヒト由来ブラディオン蛋白質、それをコードするｄｎａ及びそれらの使用
PT1141014E (pt)	1999-01-06	2005-04-29	Genentech Inc	Variante mutante do factor de crescimento semelhante a insulina (igf-i)
JP4360758B2 (ja)	1999-04-08	2009-11-11	ジェネンテック・インコーポレーテッド	逆の電荷のポリペプチド類をベースにした組成物
US6040292A (en) *	1999-06-04	2000-03-21	Celtrix Pharmaceuticals, Inc.	Methods for treating diabetes
WO2001087323A2 (en)	2000-05-16	2001-11-22	Genentech, Inc.	Method for treating cartilage disorders
IL156435A0 (en)	2001-02-09	2004-01-04	Genentech Inc	Crystallization of igf-1
US7071300B2 (en)	2001-03-14	2006-07-04	Genentech, Inc.	IGF antagonist peptides
US20040138116A1 (en) *	2002-08-30	2004-07-15	Vincent Geenen	Tolerogenic approach for type 1 diabetes
US20200376028A1 (en) *	2017-04-10	2020-12-03	Yoram Palti	Methods and Compounds for Treating Diabetes
KR20230090336A (ko) *	2020-10-13	2023-06-21	베타바이브 리미티드	당뇨병 및 관련된 대사성 질환을 치료하기 위한 방법 및 화합물
US12447198B2 (en)	2021-10-12	2025-10-21	Betavive Ltd.	Peptides and fragments for treating diabetes and associated metabolic diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU624596B2 (en) *	1987-12-16	1992-06-18	Genesis Systems Corporation	Method and system for detection and treatment of premenstrual syndrome
US4988675A (en) *	1988-02-05	1991-01-29	Ciba-Geigy Corporation	Method for preventing secondary effects
GB8819826D0 (en) *	1988-08-20	1988-09-21	Kabivitrum Ab	Glycosylated igf-1

1989
- 1989-09-08 GB GB898920381A patent/GB8920381D0/en active Pending
1990
- 1990-09-10 EP EP90913512A patent/EP0490955B1/de not_active Expired - Lifetime
- 1990-09-10 DE DE69027217T patent/DE69027217T2/de not_active Expired - Lifetime
- 1990-09-10 WO PCT/GB1990/001399 patent/WO1991003253A1/en not_active Ceased
- 1990-09-10 AT AT90913512T patent/ATE138578T1/de not_active IP Right Cessation
- 1990-09-10 ES ES90913512T patent/ES2087162T3/es not_active Expired - Lifetime
- 1990-09-10 DK DK90913512.1T patent/DK0490955T3/da active
- 1990-09-10 AU AU63580/90A patent/AU642665B2/en not_active Ceased
- 1990-09-10 JP JP2512643A patent/JP2513360B2/ja not_active Expired - Lifetime
- 1990-09-10 CA CA002066227A patent/CA2066227A1/en not_active Abandoned
1995
- 1995-03-27 US US08/412,222 patent/US5674845A/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
WO1991003253A1 (en)	1991-03-21
GB8920381D0 (en)	1989-10-25
ES2087162T3 (es)	1996-07-16
US5674845A (en)	1997-10-07
EP0490955B1 (de)	1996-05-29
DE69027217T2 (de)	1996-10-02
AU642665B2 (en)	1993-10-28
ATE138578T1 (de)	1996-06-15
JP2513360B2 (ja)	1996-07-03
JPH05504547A (ja)	1993-07-15
AU6358090A (en)	1991-04-08
DE69027217D1 (de)	1996-07-04
EP0490955A1 (de)	1992-06-24
CA2066227A1 (en)	1991-03-09

Publication	Publication Date	Title
DK0490955T3 (da)	1996-06-24	Behandling af insulinresistent diabetes
ATE50493T1 (de)	1990-03-15	Ibuprofen enthaltendes arzneimittel.
NO892303D0 (no)	1989-06-05	Stabilisert fgf-sammensetning og fremstilling derav.
NO2002009I2 (no)	2004-10-11	Tiotropium
IE882583L (en)	1989-06-29	Treatment of wounds
ATE81858T1 (de)	1992-11-15	6-thioxanthinderivate.
IE873245L (en)	1988-06-17	Administering a deoxythymidine
DE3770830D1 (de)	1991-07-25	Zubereitung von pregnanolol in einer stabilen oel-in-wasser-emulsion.
ES472847A1 (es)	1979-10-16	Procedimiento para la preparacion de la 2-bromoergosina y sus sales acidas de adicion
BG60324B2 (en)	1994-07-25	New somatotropines
DE3781488D1 (de)	1992-10-08	Pharmazeutische zusammensetzung, enthaltend 2',3'-dideoxycytidin-2'-en(2',3'-dideoxy-2',3'-didehydrocytidin) zur behandlung von mit retrovirus infizierten patienten.
IE822064L (en)	1983-02-27	Composition containing human insulin and c-peptide
AU1334792A (en)	1993-10-05	Compositions containing ranitidine/bismuth carboxylates salts
IE882529L (en)	1989-03-01	Platinum Coordination Compound
HK17880A (en)	1980-04-11	N-(1'-allyl-2'-pyrrolidylmethyl)-2,3-dimethoxy-5-sulphamoylbenzamide and derivatives
IE870277L (en)	1987-08-04	5-substituted octahydroindolizines
JPS6463342A (en)	1989-03-09	Stabilization of glutathione-containing composition
EP0269739A4 (de)	1988-08-23	1,5-disubstituierte imizadole.
KR880000094A (ko)	1988-03-23	위염치료제
KR840004431A (ko)	1984-10-15	히단토인 치료제
SE7706192L (sv)	1977-11-29	Antimikrobielle paste
JPS52133918A (en)	1977-11-09	Optically active beta-amino acid and its preparation
JPS536417A (en)	1978-01-20	Insulin composition for rectal infusion
GB1507623A (en)	1978-04-19	Penicillin and its preparation and use
עירי ריצ'י	1987	The Social Self